VKTX · US market

Viking Therapeutics Inc

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$3.56bnFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E-6.66×
Latest-quarter run-rate P/E-6.95×
Trailing P/SUnavailable
Latest-quarter run-rate P/SUnavailable

Calculation inputs

Trailing earnings
-US$534.80m
Latest-quarter run-rate earnings
-US$512.09m
Latest fiscal-year earnings
-US$359.64m
Trailing revenue
US$0.00
Latest-quarter run-rate revenue
US$0.00
Latest fiscal-year revenue
Unavailable

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

  • XBI · State Street SPDR S&P Biotech ETF1.10% weight · Holdings dated 21 August 2026
  • ATHAX · American Century Heritage Fund A Class0.91% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • DSCIX · Dana Epiphany Small Cap Equity Fund Institutional Class0.88% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • RMBMX · RMB SMID Cap Fund Class I0.84% weight · Holdings dated 30 June 2026
  • SGRW · Harbor Active Small Cap Growth ETF0.79% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • ACRSX · Columbia Acorn Fund Class S0.52% weight · Holdings dated 30 June 2026
  • FMED · Fidelity Disruptive Medicine ETF0.43% weight · Holdings dated 31 May 2026
  • FXH · First Trust Health Care AlphaDEX Fund0.39% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • PSMLX · Principal SmallCap Fund Class R60.32% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • USCAX · Victory Small Cap Stock Fund0.23% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.